Axcelis Technologies Second Quarter 2025 Earnings: Beats Expectations

NasdaqGS:ACLS 1 Year Share Price vs Fair Value
NasdaqGS:ACLS 1 Year Share Price vs Fair Value
Explore Axcelis Technologies's Fair Values from the Community and select yours
Advertisement

Axcelis Technologies (NASDAQ:ACLS) Second Quarter 2025 Results

Key Financial Results

  • Revenue: US$194.5m (down 24% from 2Q 2024).
  • Net income: US$31.4m (down 38% from 2Q 2024).
  • Profit margin: 16% (down from 20% in 2Q 2024). The decrease in margin was driven by lower revenue.
  • EPS: US$0.98 (down from US$1.56 in 2Q 2024).
earnings-and-revenue-growth
NasdaqGS:ACLS Earnings and Revenue Growth August 6th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Axcelis Technologies Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 68%.

Looking ahead, revenue is expected to decline by 1.9% p.a. on average during the next 3 years, while revenues in the Semiconductor industry in the US are expected to grow by 17%.

Performance of the American Semiconductor industry.

The company's shares are up 6.6% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Axcelis Technologies you should know about.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MI
mitchell_lawler
mitchell_lawler

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap. cover
179
PR
pri_dlp7z

Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.

About NasdaqGS:ACLS

Axcelis Technologies

Designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.

Flawless balance sheet with moderate growth potential.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$520.4% undervalued
55 users have followed this narrative
3 users have commented on this narrative
7 users have liked this narrative
JO
John_Eric
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.7% undervalued
101 users have followed this narrative
2 users have commented on this narrative
16 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8912.1% undervalued
14 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k22.1% undervalued
39 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative

Updated Narratives

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

EverQuote and an Asymmetric Investment Opportunity

Fair Value:US$3834.4% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
RI
7974 logo
richard_53rym on Nintendo ·

Nintendo facing the Ram shortage situation

Fair Value:JP¥9.62k8.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RI
richard_khp08
CIGN logo
richard_khp08 on Cigna Group ·

Cigna Group (CI) : la machine à cash-flow mal-aimée du secteur de la santé

Fair Value:€29219.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.6% undervalued
332 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9114.6% overvalued
185 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.3% undervalued
211 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

MA
MRNA logo
Madave on Moderna ·

Aged like wine

1
|
0
ZD
Zdend1
FDC logo
Zdend1 on FDC Consolidated Holdings ·

A well thought out narrative! Keep me updated.

1
|
0